PLUS Products (PLUS.C) partnered with Israeli-based CannRx Biosciences today to enhance and improve-upon the onset time for their gummies and other cannabis-infused products, according to a press release. CannRx…
cannabinoids
Xphyto Therapeutics (XPHY.C) subsidiary Xphyto Therapeutics entered into an agreement with Applied Pharmaceutical Innovation for the synthesis of pharma-grade psychedelic compounds and development of standard operating procedures to attract…
Nextleaf Solutions (OILS.C) subsidiary, Nextleaf Labs, inked a hemp processing agreement with BC-based CBD products producer, Green Light Solutions, according to a press release. The processing agreement, more specifically,…
WeedMD (WMD.V) acquired a licensing amendment from Health Canada today allowing them expanded privileges, including the ability to produce, package, sell and distribute cannabis in all formats from its…
Nutritional High International (EAT.C) signed an LOI to acquire Kruzo LLC, a company involved in development and research of products surrounding the psychoactive cacti peyote, as well as other…
Nextleaf Solutions (OILS.C) continues to stack up the patents for extracting and separating cannabinoids and terpenes, stretching the reach of their intellectual property to include North America, Asia and…
Inmed Pharmaceuticals (IN.T) filed a patent co-operation treaty (PCT) application relating to the potential for cannabinoids to prevent neuron damage associated with glaucoma. The patent application is called “Compositions…